Background: suppressor of cytokine signaling-1 and -3 (sOcs-1 and sOcs-3) are two important negative regulators in the insulin-signaling pathway, and their overexpression may aggravate insulin resistance. subjects with insulin resistance are often obese and have increased expressions of sOcs-1 and sOcs-3. We speculated that sOcs-1 and sOcs-3 may be involved in abnormal deposition of adipose tissues during insulin resistance. Methods: a catch-up growth intrauterine growth retardation (cG-IUGR) rat model with insulin resistance was established; mRNa and protein expression of sOcs-1, sOcs-3, the ccaaT/enhancer binding protein (c/eBPα), and peroxisome proliferator-activated receptor (PPaRγ) in adipose tissue were measured by real-time PcR and western blot; plasmids carrying small hairpin RNas (shRNas) targeting the SOCS-1and SOCS-3 genes were constructed and transfected into preadipocytes, which were then induced to mature. at 72 h after differentiation was induced, the expressions of c/eBPα and PPaRγ, two important molecules promoting the differentiation of preadipocytes, were detected. results: expressions of sOcs-1, sOcs-3, c/eBPα, and PPaRγ were markedly increased in adipose tissues of cG-IUGR rats, whereas the expressions of c/eBPα and PPaRγ were significantly reduced after gene silencing of SOCS-1 or SOCS-3 in adipocytes. conclusion: Overexpression of sOcs-1 and sOcs-3 may enhance the expression of c/eBPα and PPaRγ, resulting in abnormal deposition of adipose tissues during insulin resistance.
n umerous epidemiological studies have shown that adults with intrauterine growth retardation (IUGR) have a significantly increased risk for obesity and insulin resistance (1) (2) (3) . Our previous studies showed that catch-up growth IUGR rats at the age of 12 wk had developed insulin resistance and overexpressed suppressor of cytokine signaling-1 and -3 (SOCS-1 and SOCS-3); silencing of the SOCS-1 or SOCS-3 gene improved glucose transport in muscle cells (4) . Therefore, SOCS-1 and SOCS-3 may be involved in the development of insulin resistance in the muscle cells of IUGR rats. Available evidence suggests that SOCS-1 and SOCS-3 bind to the insulin receptor, inhibiting its phosphorylation and subsequent insulin signal transduction (5, 6) . In addition, SOCS-1 and SOCS-3 can bind to substrates of insulin receptor-1 and insulin receptor-2, resulting in ubiquitination of insulin receptor substrates, which also inhibits insulin signal transduction (7) .
Insulin resistance refers to reduced sensitivity of peripheral tissues to insulin, including muscular tissues and adipose tissues, which have the highest sensitivity to insulin. Adipocytes, the main component of white adipose tissues, not only store energy but are also important endocrine organs involved in the regulation of glucose and fat metabolism (8) . Mature adipocytes are differentiated from preadipocytes, which are regulated by transcriptional factors such as the CCAAT/ enhancer binding protein (C/EBPα), peroxisome proliferatoractivated receptor (PPARγ), and adipocyte determination-and differentiation-dependent factor 1 (ADD1/SREBP1c). PPARγ can induce mRNA transcription of C/EBPα, which may promote PPARγ expression via positive feedback. Furthermore, PPARγ and C/EBPα are essential for the maintenance of differentiation and maturation of adipocytes (9, 10) . Normal differentiation of adipocytes maintains the balance of energy metabolism, whereas abnormal differentiation of adipocytes may interrupt the effects of insulin, resulting in insulin resistance.
We have successfully established a catch-up IUGR rat model with insulin resistance and constructed plasmids containing shRNA targeting SOCS-1 and SOCS-3. In the current study, we investigated the basal protein levels of SOCS-1, SOCS-3, C/EBPα, and PPARγ in adipose tissues of catch-up IUGR and appropriate-for-gestational-age (AGA) rats. We speculated that SOCS-1 and SOCS-3 may regulate the differentiation of preadipocytes via C/EBPα and PPARγ, leading to the abnormal accumulation of adipose tissues, which is the main cause of insulin resistance in adipose tissues and even the body as a whole.
Results

Increased Expression of Basal SOCS-1 and SOCS-3 Protein in Adipose Tissue of IUGR Rats
To investigate whether there is a higher SOCS-1 and SOCS-3 protein level in the adipose tissue of IUGR rats at age 12 wk, we examined the subcutaneous and perirenal adipose tissues by Articles Zheng et al.
western blotting before SOCS-1 and SOCS-3 gene silencing. As compared with the AGA group, the expression of SOCS-1 and SOCS-3 in the subcutaneous and perirenal fat of IUGR rats was dramatically increased (P < 0.05) (Figure 1 ).
Increased Expression of Basal C/EBPα and PPARγ Protein in Adipose Tissue of IUGR Rats
C/EBPα and PPARγ basal protein level in adipose tissue was also detected by western blotting in IUGR and AGA rats before SOCS-1 and SOCS-3 gene silencing. As shown in Figure 2 , similar to SOCS-1 and SOCS-3, the protein level of C/EBPα and PPARγ in the subcutaneous and perirenal fat of IUGR rats was markedly increased as compared with the levels in AGA rats (P < 0.05).
Downregulation of SOCS-1 Expression Reduces the C/EBPα and PPARγ mRNA and Protein Level in Adipose Tissue
To investigate the relationship between SOCS-1 and the C/EBPα, the expression of PPARγ in adipose tissue, we knocked out the SOCS-1 gene in adipocytes with shRNA-SOCS-1 and then induced it in mature cells. We tested the mRNA expression of C/EBPα and PPARγ by real-time PCR and the protein level by western blotting 3 d after differentiation induction. As shown in Table 1 , the mRNA expressions of C/EBPα and PPARγ were significantly decreased after silencing of the SOCS-1 gene as compared with those of the control group (1.39 ± 0.35 vs. 3.01 ± 0.72, P < 0.05; 1.30 ± 0.36 vs. 2.34 ± 0.18, P < 0.05). C/EBPα and PPARγ protein levels were also markedly reduced after silencing of the SOCS-1 gene as compared with those of the AGA group (P < 0.05) (Figure 3) .
Downregulation of SOCS-3 Expression Reduces the C/EBPα and PPARγ mRNA and Protein Level in Adipose Tissue
The relationship between SOCS-3 and the C/EBPα, the expression of PPARγ in adipose tissue, was also investigated by the same method as mentioned above. The result shows the same effect of SOCS-1 and SOCS-3 gene downregulation on C/EBPα, a) were quantitated densitometrically and for quantitation of C/eBPα and PPARγ. the black bar refers to treatment with sOCs-1 shRNA, whereas the white bar indicates negative control. Data are presented as mean ± sD of the relative immunoreactivities (n = 3). Groups are indicated as control group (negative) and sOCs-1 shRNA group. **P < 0.01 as compared with negative group. eBP, enhancer binding protein; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PPAR, peroxisome proliferator-activated receptor; shRNA, small hairpin RNA; sOCs, suppressor of cytokine signaling. 
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Preadipocyte differentiation/maturation the expression of PPARγ. As compared with the control group, the mRNA expression of C/EBPα and PPARγ was significantly reduced (1.50 ± 0.47 vs. 2.27 ± 0.59, P < 0.05; 1.83 ± 0.88 vs. 4.33 ± 0.78, P < 0.01; Table 1 ) and the protein level of C/EBPα and PPARγ at 3 d after differentiation induction was also significantly reduced following the SOCS-3 gene silencing (P < 0.05; Figure 4 ).
DIsCussION
In clinical practice, the rapid deposition of adipose tissues has been noted in IUGR subjects, resulting in obesity and insulin resistance. The Third National Health and Nutrition Examination Survey in the United States revealed that the body weight of small-for-gestational-age subjects was still lower than that of normal subjects although sufficient nutrition had been administered. In addition, small-for-gestationalage subjects had high proportions of adipose tissue, and the amount of subcutaneous adipose tissue and hip circumference were larger than those in normal subjects (11) . Our previous studies showed that the IUGR rats had a higher BMI as compared with the control group (4). The molecular mechanisms underlying the regulation of adipocyte differentiation have been extensively studied in recent years. Many molecules are involved in the differentiation of preadipocytes into mature adipocytes. C/EBPα and PPARγ play important roles among these molecules: PPARγ can induce the maturation of adipocytes and regulate the expression of adipogenesis-related genes, whereas C/EBPα can regulate the terminal differentiation of adipocytes (12) (13) (14) (15) . Thus, the overdifferentiation of adipocytes and abnormal deposition of adipose tissues might be related to the increased expression of C/EBPα and PPARγ. On the basis of the results of the current study, the expression of C/EBPα and PPARγ as measured in an animal model demonstrated the above-mentioned hypothesis.
Given that C/EBPα and PPARγ can promote the maturation of adipocytes, leading to obesity, we investigated obesity in the current study. As is well known, insulin can promote adipogenesis and inhibit the degradation of adipose tissues. At the late stage of IUGR, insulin resistance and hyperinsulinemia may develop. Although the development of insulin resistance involves multiple molecules and multiple signaling pathways, the specific mechanisms for insulin resistance development are still poorly understood (16) (17) (18) . It has been demonstrated that SOCS-1 and SOCS-3 can promote the development of insulin resistance (5-7), and obese subjects with insulin resistance have been found to have increased expression of SOCS-1 and SOCS-3 (5, 14) . Thus, we examined the expression of SOCS-1 and SOCS-3 in the subcutaneous adipose tissues of catch-up IUGR rats, and the results demonstrated increased expression of SOCS-1 and SOCS-3 as compared with normal rats. It is possible that increased expression of SOCS-1 and SOCS-3 can induce insulin resistance, leading to hyperinsulinemia, which facilitates the formation and deposition of adipose tissues. Alternatively, SOCS-1 and SOCS-3 may directly promote the expression of PPARγ and C/EBPα, resulting in adipogenesis and obesity.
To investigate these hypotheses, we designed shRNAs targeting SOCS-1 and SOCS-3, which were used to silence the expression of SOCS-1 and SOCS-3 during the differentiation of preadipocytes. We then measured the expression of PPARγ and C/EBPα. Induction of preadipocyte differentiation with a cocktail of steroids is a classic method that has high efficiency and can be completed within 1 wk. As shown in the study by Ntambi and Young-Cheul (13), the expression of C/EBPα and PPARγ reached a high level 3 d after differentiation induction. Therefore, we measured the expression of C/EBPα and PPARγ at this same time point. Our results showed that there was positive correlation between silencing of the SOCS-1 and SOCS-3 genes and the expression of C/EBPα and PPARγ, and that silencing of the SOCS-1 and SOCS-3 genes could significantly reduce the expression of C/EBPα and PPARγ. Thus, we speculate that abnormally increased expression of SOCS-1 and SOCS-3 promote the expression of C/EBPα and PPARγ in the adipose tissues, facilitating the formation and deposition of adipose tissues. In the current investigation, we downregulated the gene expressions of SOCS-1 and SOCS-3 in preadipocytes and then induced them in mature cells. At 72 h after differentiation, we determined the expressions of C/EBPα and PPARγ, two key molecules in the differentiation of preadipocytes. After transfecting the most effective shRNA recombinant plasmids into IUGR adipocytes, not only was a significant inhibition in SOCS-1 and SOCS-3 at both the mRNA and protein levels detected, but a reduction effect on the expression of C/EBPα and PPARγ was also detected.
Collectively, our results demonstrated that SOCS-1, SOCS-3, C/EBPα, and PPARγ expression are markedly increased in IUGR rats. During the differentiation of preadipocytes, silencing of SOCS-1 and SOCS-3 genes by using shRNAs can significantly Blots as shown in (a) were quantitated densitometrically and for quantitation of C/eBPα and PPARγ. the black bar refers to treatment with sOCs-3 shRNA, whereas the white bar indicates negative control. Data are presented as mean ± sD of the relative immunoreactivities (n = 3). Groups are indicated as control group (negative) and sOCs-3 shRNA group. *P < 0.05, **P < 0.01 as compared with negative group. eBP, enhancer binding protein; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IuGR, intrauterine growth retardation; PPAR, peroxisome proliferator-activated receptor; shRNA, small hairpin RNA; sOCs, suppressor of cytokine signaling.
